North America Pharmacogenomics Market (2025-2031) | Outlook, Opportunities, Value, Segmentation, Pricing Analysis, Revenue, Trends, Supply, Industry, Consumer Insights, Investment Trends, Segments, Forecast, Strategy, Drivers, Analysis, Share, Demand, Growth, Challenges, Size, Restraints, Competitive, Competition, Companies, Strategic Insights

Market Forecast by Countries (United States (US), Canada, Rest of North America), By Technology (Polymerase Chain Reaction, Microarray, DNA Sequencing, Mass Spectrometry, Electrophoresis, Others), By Application (Oncology, Infectious Diseases, Cardiovascular Diseases, Neurological Diseases, Psychiatry, Pain Management, Others), By End User (Hospitals and Clinics, Academic and Research Institutes) And Competitive Landscape
Product Code: ETC13167507 Publication Date: Apr 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 150 No. of Figures: 55 No. of Tables: 32

Key Highlights of the Report:

  • North America Pharmacogenomics Market Outlook
  • Market Size of North America Pharmacogenomics Market, 2024
  • Forecast of North America Pharmacogenomics Market, 2031
  • Historical Data and Forecast of North America Pharmacogenomics Revenues & Volume for the Period 2021 - 2031
  • North America Pharmacogenomics Market Trend Evolution
  • North America Pharmacogenomics Market Drivers and Challenges
  • North America Pharmacogenomics Price Trends
  • North America Pharmacogenomics Porter's Five Forces
  • North America Pharmacogenomics Industry Life Cycle
  • Historical Data and Forecast of North America Pharmacogenomics Market Revenues & Volume By Technology for the Period 2021 - 2031
  • Historical Data and Forecast of North America Pharmacogenomics Market Revenues & Volume By Polymerase Chain Reaction for the Period 2021 - 2031
  • Historical Data and Forecast of North America Pharmacogenomics Market Revenues & Volume By Microarray for the Period 2021 - 2031
  • Historical Data and Forecast of North America Pharmacogenomics Market Revenues & Volume By DNA Sequencing for the Period 2021 - 2031
  • Historical Data and Forecast of North America Pharmacogenomics Market Revenues & Volume By Mass Spectrometry for the Period 2021 - 2031
  • Historical Data and Forecast of North America Pharmacogenomics Market Revenues & Volume By Electrophoresis for the Period 2021 - 2031
  • Historical Data and Forecast of North America Pharmacogenomics Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Pharmacogenomics Market Revenues & Volume By Technology for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Pharmacogenomics Market Revenues & Volume By Polymerase Chain Reaction for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Pharmacogenomics Market Revenues & Volume By Microarray for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Pharmacogenomics Market Revenues & Volume By DNA Sequencing for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Pharmacogenomics Market Revenues & Volume By Mass Spectrometry for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Pharmacogenomics Market Revenues & Volume By Electrophoresis for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Pharmacogenomics Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Pharmacogenomics Market Revenues & Volume By Technology for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Pharmacogenomics Market Revenues & Volume By Polymerase Chain Reaction for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Pharmacogenomics Market Revenues & Volume By Microarray for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Pharmacogenomics Market Revenues & Volume By DNA Sequencing for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Pharmacogenomics Market Revenues & Volume By Mass Spectrometry for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Pharmacogenomics Market Revenues & Volume By Electrophoresis for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Pharmacogenomics Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Pharmacogenomics Market Revenues & Volume By Technology for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Pharmacogenomics Market Revenues & Volume By Polymerase Chain Reaction for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Pharmacogenomics Market Revenues & Volume By Microarray for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Pharmacogenomics Market Revenues & Volume By DNA Sequencing for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Pharmacogenomics Market Revenues & Volume By Mass Spectrometry for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Pharmacogenomics Market Revenues & Volume By Electrophoresis for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Pharmacogenomics Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of North America Pharmacogenomics Market Revenues & Volume By Application for the Period 2021 - 2031
  • Historical Data and Forecast of North America Pharmacogenomics Market Revenues & Volume By Oncology for the Period 2021 - 2031
  • Historical Data and Forecast of North America Pharmacogenomics Market Revenues & Volume By Infectious Diseases for the Period 2021 - 2031
  • Historical Data and Forecast of North America Pharmacogenomics Market Revenues & Volume By Cardiovascular Diseases for the Period 2021 - 2031
  • Historical Data and Forecast of North America Pharmacogenomics Market Revenues & Volume By Neurological Diseases for the Period 2021 - 2031
  • Historical Data and Forecast of North America Pharmacogenomics Market Revenues & Volume By Psychiatry for the Period 2021 - 2031
  • Historical Data and Forecast of North America Pharmacogenomics Market Revenues & Volume By Pain Management for the Period 2021 - 2031
  • Historical Data and Forecast of North America Pharmacogenomics Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Pharmacogenomics Market Revenues & Volume By Application for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Pharmacogenomics Market Revenues & Volume By Oncology for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Pharmacogenomics Market Revenues & Volume By Infectious Diseases for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Pharmacogenomics Market Revenues & Volume By Cardiovascular Diseases for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Pharmacogenomics Market Revenues & Volume By Neurological Diseases for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Pharmacogenomics Market Revenues & Volume By Psychiatry for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Pharmacogenomics Market Revenues & Volume By Pain Management for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Pharmacogenomics Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Pharmacogenomics Market Revenues & Volume By Application for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Pharmacogenomics Market Revenues & Volume By Oncology for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Pharmacogenomics Market Revenues & Volume By Infectious Diseases for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Pharmacogenomics Market Revenues & Volume By Cardiovascular Diseases for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Pharmacogenomics Market Revenues & Volume By Neurological Diseases for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Pharmacogenomics Market Revenues & Volume By Psychiatry for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Pharmacogenomics Market Revenues & Volume By Pain Management for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Pharmacogenomics Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Pharmacogenomics Market Revenues & Volume By Application for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Pharmacogenomics Market Revenues & Volume By Oncology for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Pharmacogenomics Market Revenues & Volume By Infectious Diseases for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Pharmacogenomics Market Revenues & Volume By Cardiovascular Diseases for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Pharmacogenomics Market Revenues & Volume By Neurological Diseases for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Pharmacogenomics Market Revenues & Volume By Psychiatry for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Pharmacogenomics Market Revenues & Volume By Pain Management for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Pharmacogenomics Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of North America Pharmacogenomics Market Revenues & Volume By End User for the Period 2021 - 2031
  • Historical Data and Forecast of North America Pharmacogenomics Market Revenues & Volume By Hospitals and Clinics for the Period 2021 - 2031
  • Historical Data and Forecast of North America Pharmacogenomics Market Revenues & Volume By Academic and Research Institutes for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Pharmacogenomics Market Revenues & Volume By End User for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Pharmacogenomics Market Revenues & Volume By Hospitals and Clinics for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Pharmacogenomics Market Revenues & Volume By Academic and Research Institutes for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Pharmacogenomics Market Revenues & Volume By End User for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Pharmacogenomics Market Revenues & Volume By Hospitals and Clinics for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Pharmacogenomics Market Revenues & Volume By Academic and Research Institutes for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Pharmacogenomics Market Revenues & Volume By End User for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Pharmacogenomics Market Revenues & Volume By Hospitals and Clinics for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Pharmacogenomics Market Revenues & Volume By Academic and Research Institutes for the Period 2021 - 2031
  • TOC_BulkHighlights_15701to15800__nusa.csv
  • North America Pharmacogenomics Market - Key Performance Indicators
  • North America Pharmacogenomics Market - Import Export Trade Statistics
  • North America Pharmacogenomics Market - Opportunity Assessment By Countries
  • North America Pharmacogenomics Market - Opportunity Assessment By Technology
  • North America Pharmacogenomics Market - Opportunity Assessment By Application
  • North America Pharmacogenomics Market - Opportunity Assessment By End User
  • North America Pharmacogenomics Market - Top Companies Market Share
  • North America Pharmacogenomics Market - Top Companies Profiles
  • North America Pharmacogenomics Market - Comparison of Players in Technical and Operating Parameters
  • North America Pharmacogenomics Market - Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6W market outlook report help businesses in making decisions?
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Do you also provide customisation in the market study?
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

North America Pharmacogenomics Market

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 North America Pharmacogenomics Market Overview

3.1 North America Regional Macro Economic Indicators

3.2 North America Pharmacogenomics Market Revenues & Volume, 2021 & 2031F

3.3 North America Pharmacogenomics Market - Industry Life Cycle

3.4 North America Pharmacogenomics Market - Porter's Five Forces

3.5 North America Pharmacogenomics Market Revenues & Volume Share, By Countries, 2021 & 2031F

3.6 North America Pharmacogenomics Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.7 North America Pharmacogenomics Market Revenues & Volume Share, By Application, 2021 & 2031F

3.8 North America Pharmacogenomics Market Revenues & Volume Share, By End User, 2021 & 2031F

4 North America Pharmacogenomics Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 North America Pharmacogenomics Market Trends

6 North America Pharmacogenomics Market, 2021 - 2031

6.1 North America Pharmacogenomics Market, Revenues & Volume, By Technology, 2021 - 2031

6.1.1 Overview & Analysis

6.1.2 North America Pharmacogenomics Market, Revenues & Volume, By Polymerase Chain Reaction, 2021 - 2031

6.1.3 North America Pharmacogenomics Market, Revenues & Volume, By Microarray, 2021 - 2031

6.1.4 North America Pharmacogenomics Market, Revenues & Volume, By DNA Sequencing, 2021 - 2031

6.1.5 North America Pharmacogenomics Market, Revenues & Volume, By Mass Spectrometry, 2021 - 2031

6.1.6 North America Pharmacogenomics Market, Revenues & Volume, By Electrophoresis, 2021 - 2031

6.1.7 North America Pharmacogenomics Market, Revenues & Volume, By Others, 2021 - 2031

6.2 North America Pharmacogenomics Market, Revenues & Volume, By Application, 2021 - 2031

6.2.1 Overview & Analysis

6.2.2 North America Pharmacogenomics Market, Revenues & Volume, By Oncology, 2021 - 2031

6.2.3 North America Pharmacogenomics Market, Revenues & Volume, By Infectious Diseases, 2021 - 2031

6.2.4 North America Pharmacogenomics Market, Revenues & Volume, By Cardiovascular Diseases, 2021 - 2031

6.2.5 North America Pharmacogenomics Market, Revenues & Volume, By Neurological Diseases, 2021 - 2031

6.2.6 North America Pharmacogenomics Market, Revenues & Volume, By Psychiatry, 2021 - 2031

6.2.7 North America Pharmacogenomics Market, Revenues & Volume, By Pain Management, 2021 - 2031

6.2.8 North America Pharmacogenomics Market, Revenues & Volume, By Others, 2021 - 2031

6.3 North America Pharmacogenomics Market, Revenues & Volume, By End User, 2021 - 2031

6.3.1 Overview & Analysis

6.3.2 North America Pharmacogenomics Market, Revenues & Volume, By Hospitals and Clinics, 2021 - 2031

6.3.3 North America Pharmacogenomics Market, Revenues & Volume, By Academic and Research Institutes, 2021 - 2031

7 North America Pharmacogenomics Market, By Countries, 2021 - 2031

7.1 Overview & Analysis

7.2 North America Pharmacogenomics Market, Revenues & Volume, By Technology, 2021 - 2031

7.2.1 United States (US) Pharmacogenomics Market, Revenues & Volume, By Technology, 2021 - 2031

7.2.2 Canada Pharmacogenomics Market, Revenues & Volume, By Technology, 2021 - 2031

7.2.3 Rest of North America Pharmacogenomics Market, Revenues & Volume, By Technology, 2021 - 2031

7.3 North America Pharmacogenomics Market Revenues & Volume Share, By Application, 2021 & 2031F

7.3.1 United States (US) Pharmacogenomics Market, Revenues & Volume, By Application, 2021 - 2031

7.3.2 Canada Pharmacogenomics Market, Revenues & Volume, By Application, 2021 - 2031

7.3.3 Rest of North America Pharmacogenomics Market, Revenues & Volume, By Application, 2021 - 2031

7.4 North America Pharmacogenomics Market, Revenues & Volume, By End User, 2021 - 2031

7.4.1 United States (US) Pharmacogenomics Market, Revenues & Volume, By End User, 2021 - 2031

7.4.2 Canada Pharmacogenomics Market, Revenues & Volume, By End User, 2021 - 2031

7.4.3 Rest of North America Pharmacogenomics Market, Revenues & Volume, By End User, 2021 - 2031

8 North America Pharmacogenomics Market Key Performance Indicators

9 North America Pharmacogenomics Market - Export/Import By Countries Assessment

10 North America Pharmacogenomics Market - Opportunity Assessment

10.1 North America Pharmacogenomics Market Opportunity Assessment, By Countries, 2021 & 2031F

10.2 North America Pharmacogenomics Market Opportunity Assessment, By Technology, 2021 & 2031F

10.3 North America Pharmacogenomics Market Opportunity Assessment, By Application, 2021 & 2031F

10.4 North America Pharmacogenomics Market Opportunity Assessment, By End User, 2021 & 2031F

11 North America Pharmacogenomics Market - Competitive Landscape

11.1 North America Pharmacogenomics Market Revenue Share, By Companies, 2022

11.2 North America Pharmacogenomics Market Competitive Benchmarking, By Operating and Technical Parameters

12 Top 10 Company Profiles

13 Recommendations

14 Disclaimer

Related Report Available


×
Go to New Report No! I want to read this
Pricing
  • Single User License
    $ 4,560
  • Department License
    $ 5,055
  • Site License
    $ 5,595
  • Global License
    $ 6,000
Buy Now
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Search

Related Reports

Industry Events and Analyst Meet

RoTIC Symposium 2025 – Middle East Rotating Machinery Technology & Innovation Symposium

RoTIC Symposium 2025 – Middle East Rotating Machinery Technology & Innovation Symposium

2nd CYBER FIRST QATAR EDITION

2nd CYBER FIRST QATAR EDITION

Truck Trailer and Tyre Expo 2025

Truck Trailer and Tyre Expo 2025

Dairy, Food and Bakery Expo 2025

Dairy, Food and Bakery Expo 2025

Dairy and Food Expo 2025

Dairy and Food Expo 2025

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All

6WResearch In News

Read All
About Us

6Wresearch is the premier, one stop market intelligence and advisory center, known for its best in class business research and consulting activity. We provide industry research reports and consulting service across different industries and geographies which provide industry players an in-depth coverage and help them in decision making before investing or enter into a particular geography.

  • twitter logo
  • facebook logo
  • linkedin logo
Company
About Us
Events
Careers
Privacy Policy
Terms & Conditions
Delivery
Disclaimer
Contact Us
Services
ADVISORY & CONSULTING
FEASIBILITY STUDIES & BUSINESS PLAN
COMPETITORS INTELLIGENCE
CHANNEL & DISTRIBUTION STRATEGY
PROCUREMENT INTELLIGENCE
CUSTOMER BEHAVIOR ANALYSIS
BUSINESS MODELS & KEY MANAGEMENT PRACTICES
CRITICAL SUCCESS FACTORS ANALYSIS
Verticals
Aerospace and Defense
Chemicals and Materials
Semiconductor and Electronics
Power, Utility and Oil & Gas
Heavy Industry
Telecom, Information & Communication Technology
Healthcare
Automotive
Consumer Staples
Banking, Financial and Legal Services
Metals and Minerals
Media and Entertainment
Miscellaneous
©2025 6Wresearch, All Right Reserved